Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab+carboplatin+nab-paclitaxel (A+CnP). This is an ASCO ...
Evaluating the efficacy and mechanisms of action of seriniquinone against pediatric neuroblastoma. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results